Abstract
Wnt pathways are critical for embryonic development and adult tissue homeostasis in all multicellular animals. Many regulatory mechanisms exist to control proper signaling output. Recent studies suggest that cell surface Wnt receptor level is controlled by ubiquitination, and serve as a critical regulatory point of Wnt pathway activity as it determines the responsiveness of cells to Wnt signal. Here, we describe flow cytometry, cell surface protein biotinylation, and immunofluorescence pulse-chase methods to probe the surface expression, ubiquitination, and internalization of the Wnt receptors FZD and LRP6.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149(6):1192–1205
Hsieh JC et al (1999) A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398(6726):431–436
Piccolo S et al (1999) The head inducer cerberus is a multifunctional antagonist of nodal. BMP and Wnt signals. Nature 397(6721):707–710
Semenov MV et al (2001) Head inducer dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11(12):951–961
Zhang X et al (2012) Tiki1 is required for head formation via Wnt cleavage-oxidation and inactivation. Cell 149(7):1565–1577
Kakugawa S et al (2015) Notum deacylates Wnt proteins to suppress signalling activity. Nature 519(7542):187–192
Mukai A et al (2010) Balanced ubiquitylation and deubiquitylation of Frizzled regulate cellular responsiveness to Wg/Wnt. EMBO J 29(13):2114–2125
Hao HX et al (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485(7397):195–200
Koo BK et al (2012) Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488(7413):665–669
Moffat LL et al (2014) The conserved transmembrane RING finger protein PLR-1 downregulates Wnt signaling by reducing Frizzled, Ror and Ryk cell-surface levels in C. elegans. Development 141(3):617–628
de Lau WB, Snel B, Clevers HC (2012) The R-spondin protein family. Genome Biol 13(3):242
Carmon KS et al (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 108(28):11452–11457
de Lau W et al (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476(7360):293–297
Glinka A et al (2011) LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep 12(10):1055–1061
Ruffner H et al (2012) R-Spondin potentiates Wnt/beta-catenin signaling through orphan receptors LGR4 and LGR5. PLoS One 7(7):e40976
Chen PH et al (2013) The structural basis of R-spondin recognition by LGR5 and RNF43. Genes Dev 27(12):1345–1350
Peng WC et al (2013) Structure of stem cell growth factor R-spondin 1 in complex with the ectodomain of its receptor LGR5. Cell Rep 3(6):1885–1892
Peng WC et al (2013) Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling. PLoS One 8(12):e83110
Wang D et al (2013) Structural basis for R-spondin recognition by LGR4/5/6 receptors. Genes Dev 27(12):1339–1344
Xie Y et al (2013) Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin. EMBO Rep 14(12):1120–1126
Zebisch M et al (2013) Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat Commun 4:2787
Xu K et al (2013) Crystal structures of Lgr4 and its complex with R-spondin1. Structure 21(9):1683–1689
Assie G et al (2014) Integrated genomic characterization of adrenocortical carcinoma. Nat Genet 46(6):607–612
Furukawa T et al (2011) Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1:161
Jiang X et al (2013) Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A 110(31):12649–12654
Ong CK et al (2012) Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet 44(6):690–693
Ryland GL et al (2013) RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol 229(3):469–476
Wang K et al (2014) Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet 46(6):573–582
Wu J et al (2011) Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 108(52):21188–21193
Giannakis M et al (2014) RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet 46(12):1264–1266
Jiao Y et al (2014) Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol 232(4):428–435
Seshagiri S et al (2012) Recurrent R-spondin fusions in colon cancer. Nature 488(7413):660–664
Gurney A et al (2012) Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci U S A 109(29):11717–11722
Jiang X et al (2015) Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases. Mol Cell 58(3):522–533
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Jiang, X., Cong, F. (2016). Probing Wnt Receptor Turnover: A Critical Regulatory Point of Wnt Pathway. In: Barrett, Q., Lum, L. (eds) Wnt Signaling. Methods in Molecular Biology, vol 1481. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6393-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6393-5_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6391-1
Online ISBN: 978-1-4939-6393-5
eBook Packages: Springer Protocols